Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanglaite Injection in Progressive Stage IV NSCLC
NCT01640730Phase 2Terminated
- Sponsor
- Zhejiang Kanglaite Pharmaceutical Co., Ltd.
- Start
- May 2012
- Primary completion
- Oct 2012
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 2 trial of kanglaite in non-small cell lung cancer (NSCLC), sponsored by Zhejiang Kanglaite Pharmaceutical Co., Ltd.. Started May 2012; status: terminated.
02
Drugs
kanglaite
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01640730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01640730.